China Health Group Announces Board Composition and Committee Roles
China Health Group (HK:0673) has announced its board composition and committee roles, detailing the executive, non-executive, and independent non-executive directors, along with the members and chairpersons of its audit, nomination, and remuneration committees. This update clarifies the company's governance structure, which may influence its strategic direction. The current analyst rating for the stock is a Hold with a price target of HK$0.50, and the market cap stands at HK$669.6M.
China Health Group ( (HK:0673) ) just unveiled an announcement.
China Health Group Limited, a company incorporated in Bermuda and operating in Hong Kong as CHG HS Limited, has announced the composition of its board of directors and the roles within its three board committees. The announcement details the executive, non-executive, and independent non-executive directors, as well as the members and chairpersons of the audit, nomination, and remuneration committees. This update provides stakeholders with clarity on the governance structure of the company, potentially impacting its strategic direction and operational oversight.
The most recent analyst rating on (HK:0673) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on China Health Group stock, see the HK:0673 Stock Forecast page.
More about China Health Group
Average Trading Volume: 665,568
Technical Sentiment Signal: Buy
Current Market Cap: HK$669.6M
